These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24995853

  • 1. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM, Saleem IY, Roberts M.
    J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
    [Abstract] [Full Text] [Related]

  • 2. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
    Hamza Yel-S, Aburahma MH.
    Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study.
    Teaima MH, Abdel-Haleem KM, Osama R, El-Nabarawi MA, Elnahas OS.
    Drug Des Devel Ther; 2021 Mar; 15():4229-4242. PubMed ID: 34675486
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems.
    Pan RN, Chen JH, Chen RR.
    Drug Dev Ind Pharm; 2000 Sep; 26(9):989-94. PubMed ID: 10914324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M, Sadeghpoor F.
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M, Bećirević-Laćan M.
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [Abstract] [Full Text] [Related]

  • 11. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM, Kumar MT, Balasubramaniam J, Pandit JK.
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [Abstract] [Full Text] [Related]

  • 12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 13. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F, Song S, Guo Y, Zhao Q, Zhang X, Pan W, Yang X.
    Drug Deliv; 2015 Sep 14; 22(4):487-98. PubMed ID: 24524289
    [Abstract] [Full Text] [Related]

  • 14. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads.
    Aburahma MH, Hamza Yel-S.
    Pharm Dev Technol; 2011 Aug 14; 16(4):316-30. PubMed ID: 20307250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use.
    Lou H, Liu M, Wang L, Mishra SR, Qu W, Johnson J, Brunson E, Almoazen H.
    AAPS PharmSciTech; 2013 Sep 14; 14(3):950-8. PubMed ID: 23761262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.
    Hamza Yel-S, Aburahma MH.
    Pharm Dev Technol; 2010 Sep 14; 15(2):139-53. PubMed ID: 19895367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.